ABSTRACT
Carbonyl sulfur (COS) is a prominent organic sulfur pollutant commonly found in the by-product gas generated by the steel industry. A series of Sm-doped CeOx@ZrO2 catalysts were prepared for the hydrolysis catalytic removal of COS. The results showed that the addition of Sm resulted in the most significant enhancement of hydrolysis catalytic activity. The 3% Sm2O3-Ce-Ox@ZrO2 catalyst exhibited the highest activity, achieving a hydrolysis catalytic efficiency of 100% and H2S selectivity of 100% within the temperature range of 90-180 °C. The inclusion of Sm had the effect of reducing the acidity of the catalyst while increasing weak basic sites, which facilitated the adsorption and activation of COS molecules at low temperatures. Appropriate doping of Sm proved beneficial in converting active surface chemisorbed oxygen into lattice oxygen, thereby decreasing the oxidation of intermediate products and maintaining the stability of the hydrolysis reaction.
ABSTRACT
The selective removal and recovery of silver ions from an aqueous solution is necessary, owing to the toxicity, persistency, and recoverable value. Herein, we first reported that silver ions could be selectively removed from an acidic solution by utilizing redox-active covalent organic framework (COF) materials as an adsorbent, resulting in the loading of Ag nanoparticles (NPs) with a narrow size distribution onto the framework simultaneously. The redox-active COF not only showed promising performance in adsorbing silver ions but also had a high selectivity at a low pH value. Subsequently, it was found that the N sites of amine groups within the framework took responsibility for the Ag NP generation after the systematic investigation on the redox adsorption mechanism. Furthermore, the recycled Ag@COF materials could be further used as new adsorbents to remove Hg(II) ions from water via NPs as a "bridge", exhibiting ultrahigh atomic utilization (>100%). Accordingly, this work not only provides a novel insight for the use of redox-active COF in the removal of metal ions but also opens a new field for designing of functionalized COF for their potential application in diverse areas.
ABSTRACT
BACKGROUND: Conversion therapy is intended to allow achieving R0 resection after chemotherapy for tumors initially considered unresectable or partially resectable. Neoadjuvant intraperitoneal and systemic chemotherapy (NIPS) is the current conversion therapy for gastric cancer (GC) patients with peritoneal metastasis. This meta-analysis evaluated the effectiveness and safety of NIPS-combined surgery for GC patients with peritoneal metastasis. METHODS: Standard methods were used to select and analyze studies that included GC patients with peritoneal metastasis assigned to two groups, either NIPS-combined surgery or a NIPS-only control. Publications were retrieved from PubMed, EMBASE, Medline, and the Cochrane Central Register. Overall survival, conversion therapy success and R0 resection rates, and adverse events were analyzed using Stata 11.0. RESULTS: Eight of the 14 studies that were evaluated after screening the titles and abstracts of 327 retrieved publications met the selection criteria. The eight retrospective studies included 373 patients with GC and peritoneal metastasis included 265 with NIPS-combined surgery and 109 with NIPS only. Survival was significantly better with NIPS-combined surgery than with NIPS only (hazard ratio = 0.440, 95% confidence interval [CI]: 0.274-0.704; P = 0.0001; odds ratio = 1.960; 95% CI: 1.247-3.083; P = 0.004). Subgroup analysis revealed significantly better survival with S-1 Joint intravenous paclitaxel and intraperitoneal paclitaxel compared with other NIPS regimens. NIPS regimens had a higher conversion rate (effect size [ES] = 0.656; 95% CI: 0.495-0.817; P < 0.05), higher percentage of patients with R0 surgery (ES = 0.633; 95% CI: 0.568-0.699; P < 0.05), less severe adverse reactions to chemotherapy (ES = 0.030; 95% CI: 0.020-0.040; P < 0.05), and fewer postoperative complications (ES = 0.040; 95% CI: 0.020-0.050; P < 0.05). CONCLUSIONS: NIPS-combined surgical treatment was effective and safe for treating GC with peritoneal metastasis. Higher quality trials, better patient selection, and multicenter randomized controlled trials are needed to support standard treatment guidelines.
